DV
Dividend Vision

BICX Stock — BioCorRx Inc

BioCorRx Inc (BICX)

Updated October 15, 2026.

BICX is a Stock. Total return is -99.7% over the past 16.1 years, 947.1 points behind SPY at 847.4%.

BioCorRx Inc. develops and provides treatment programs for substance abuse and related disorders, including its Beat Addiction Recovery program that combines cognitive behavioral therapy, peer support via mobile app, and physician-prescribed medication, along with the UnCraveRx weight loss management program. The company is also developing injectable and implantable naltrexone products for opioid dependence and alcohol use disorders. The company does not currently distribute to shareholders.

BICX dividend yield and income

Price as of 2026-10-15.

The payment date is 01/22/2019.

BICX performance versus SPY

Price and return data through 2026-10-15.

Total return is -99.7% over the past 16.1 years, 947.1 points behind SPY at 847.4%. Over the past year its total return — price change plus distributions reinvested — is -44.4%. Its deepest 1-year drawdown was 69.3%.

WindowTotal returnCAGR
1M0.0%—
3M-19.6%—
6M-18.0%—
YTD-14.1%—
1Y-44.4%—
2Y CAGR—-8.70%
3Y CAGR—-46.20%
5Y CAGR—-42.60%
10Y CAGR—-24.00%
Since inception (16.1 years)-99.7%-29.90%

BICX key facts

Asset type
Stock
Asset class
Equity
Inception date
09/01/2010
Distribution frequency
None
Last close
$0.25 (as of 2026-10-15)
Market cap
$7,439,544
Average volume
0.0
Payment date
01/22/2019
Beta
0.206
Payout ratio
0.0%
EPS
$-0.13

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BICX risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 69.3%.

Who may consider BICX — and who may not

It is a weaker fit for investors who need monthly cash flow (BICX does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BICX

Tagged: Healthcare.

Frequently asked questions

Does BICX pay monthly?

No. BICX does not currently distribute.

When does BICX pay a dividend?

BICX does not currently distribute. The payment date is 01/22/2019.

How has BICX performed?

Total return is -99.7% over the past 16.1 years, 947.1 points behind SPY at 847.4%. Over the past year its total return — price change plus distributions reinvested — is -44.4%. Its deepest 1-year drawdown was 69.3%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.